CopyFind
Safepred Tablet
medicine 📍 IN

Safepred Tablet

50,00 ₹

Analogs of Safepred Tablet

Find cheaper analogs and generic equivalents for Safepred Tablet.

Ingredients

सक्रिय अवयव: Methylprednisolone


उत्पाद अवलोकन

About Safepred Tablet

Safepred Tablet is a medication containing the active ingredient Methylprednisolone, classified as Corticosteroid medication. Methylprednisolone, sold under the brand name Medrol among others, is a synthetic glucocorticoid, primarily prescribed for its anti-inflammatory and immunosuppressive effects. It is either used at low doses for chronic illnesses or used at high doses during acute flares.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1
  • Used for: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice
  • Used for: synthetic analogs may be used in conjunction with mineralocorticoids where applicable

Active Ingredient & Action

Methylprednisolone, the active ingredient in Safepred Tablet, belongs to the Corticosteroid medication class. INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy minera…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Safepred Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Safepred Tablet for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Safepred Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.